At 10:30a.m. (East Coast Time) on September 22nd, Navitas Life Sciences and AbbVie will present “PV Organizations Reimagined - Roadmap to Transforming into a Strategic PV Organization”, ...

September 13, 2016 Princeton, New Jersey: AbbVie and Navitas Life Sciences Present Case Study on the Evolution and Transformation of PV Organizations

At 10:30a.m. (East Coast Time) on September 22nd, Navitas Life Sciences and AbbVie will present “PV Organizations Reimagined – Roadmap to Transforming into a Strategic PV Organization”, a webinar on reimagining Pharmacovigilance (PV) organizations by transforming to become a strategic PV organization. Pharmacovigilance (also known as drug safety) is the science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects associated with pharmaceutical products.

Presenting the webinar will be Navitas’ Wilfred Gilich and AbbVie executives Dr. Linda Scarazzini, Vice President PV and Patient Safety, Jenifer Koeller, Senior Director Business Solutions PV and Patient Safety, and Kemo Yusuf, Director Business Solutions Project Management PV and Patient Safety.

AbbVie develops leading-edge therapies and innovations with a diverse product portfolio, including several market-leading medicines. AbbVie has a focused business and investment model designed to address unmet patient needs with proven commercial capabilities, infrastructure and expertise rooted in a 125 – year history as an innovative leader in advancing healthcare. Abbvie has over 28,000 employees worldwide.

Discussed will be how the landscape is rapidly changing for PV organizations and how PV organizations must respond. It will identify the anatomy of a strategic PV organization and AbbVie executives will provide a case study on the roadmap towards PPS (Pharmacovigilance and Patient Safety), AbbVie’s 2020 vision.

They will demonstrate how PPS was brought to life and the results and impact PPS has had within AbbVie so far and what lies ahead for AbbVie, in addition to key learnings for other PV organizations.

Pharmacovigliance executives can visit here to register for the webinar. For more information, click here

About Navitas:
The Navitas Life Sciences team has been assembled bringing together the proven expert teams of TAKE Life Sciences and WCI Consulting and, adding to this core, a range of experts from the worlds of Clinical Development, Regulatory, Technology, and Consulting. We have built the Navitas Life Sciences team specifically to deliver insight to our clients, to develop pragmatic solutions together, and to support their deployment and operation. We deliver advise, solutions, and services in Clinical, Regulatory, Safety, and Content Management. We are proud that our legacy businesses have served the sector for some 20 years and have allowed us to work with 100 of the top Life Science companies. Our team have now grown to over 400 staff.

We pride ourselves in our role as Expert Navigators. Interpreting market and regulatory change; driving collaboration across companies; seeking the simple solution to the complex problem; investing to enable the changes. Motivated by the success of our clients, we thrive on working together with clients, partners, and each other, across geographies, time zones, and cultures. For more information, visit


Latest News & Articles


Harmonious approach of regulatory data migration

A holistic solution platform that can manage the complexities of regulatory operations ......


Encouraging patient-centric innovation in pharma

Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions...